These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24396453)

  • 81. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics.
    Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y
    Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Self-assembled micelles based on Chondroitin sulfate/poly (d,l-lactideco-glycolide) block copolymers for doxorubicin delivery.
    Zhang H; Xu J; Xing L; Ji J; Yu A; Zhai G
    J Colloid Interface Sci; 2017 Apr; 492():101-111. PubMed ID: 28073063
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Self-assembling polymer micelle/clay nanodisk/doxorubicin hybrid injectable gels for safe and efficient focal treatment of cancer.
    Nagahama K; Kawano D; Oyama N; Takemoto A; Kumano T; Kawakami J
    Biomacromolecules; 2015 Mar; 16(3):880-9. PubMed ID: 25645815
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells.
    Sokol MB; Nikolskaya ED; Yabbarov NG; Zenin VA; Faustova MR; Belov AV; Zhunina OA; Mollaev MD; Zabolotsky AI; Tereshchenko OG; Severin ES
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1150-1158. PubMed ID: 30281905
    [TBL] [Abstract][Full Text] [Related]  

  • 85. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity.
    Pieper S; Onafuye H; Mulac D; Cinatl J; Wass MN; Michaelis M; Langer K
    Beilstein J Nanotechnol; 2019; 10():2062-2072. PubMed ID: 31728254
    [No Abstract]   [Full Text] [Related]  

  • 87. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R; Shi Ng L; Wang CH
    Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Targeted nanoparticles for simultaneous delivery of chemotherapeutic and hyperthermia agents--an in vitro study.
    Srinivasan S; Manchanda R; Lei T; Nagesetti A; Fernandez-Fernandez A; McGoron AJ
    J Photochem Photobiol B; 2014 Jul; 136():81-90. PubMed ID: 24859437
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin.
    Liu CW; Lin WJ
    Int J Nanomedicine; 2012; 7():4749-67. PubMed ID: 22973097
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
    Mosafer J; Teymouri M
    Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.
    Huang IP; Sun SP; Cheng SH; Lee CH; Wu CY; Yang CS; Lo LW; Lai YK
    Mol Cancer Ther; 2011 May; 10(5):761-9. PubMed ID: 21411714
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
    Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
    J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Anticancer Activity of Nanoparticles Based on PLGA and its Co-polymer: In-vitro Evaluation.
    Amjadi I; Rabiee M; Hosseini MS
    Iran J Pharm Res; 2013; 12(4):623-34. PubMed ID: 24523742
    [TBL] [Abstract][Full Text] [Related]  

  • 94. DOX-PLGA Nanoparticles Effectively Suppressed the Expression of Pro-Inflammatory Cytokines TNF-a, IL-6, iNOS, and IL-1β in MCF-7 Breast Cancer Cell Line.
    Hassan Al-Saeedi R; Khalaj-Kondori M; Hosseinpour Feizi MA; Hajavi J
    Rep Biochem Mol Biol; 2024 Jan; 12(4):530-539. PubMed ID: 39086585
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA.
    Zhao J; Mu X; Hou X; Zhang X; Li P; Jiang J
    Front Oncol; 2023; 13():1111855. PubMed ID: 36756155
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Nanoporous Gold Monolith for High Loading of Unmodified Doxorubicin and Sustained Co-Release of Doxorubicin-Rapamycin.
    Bhattarai JK; Neupane D; Nepal B; Demchenko AV; Stine KJ
    Nanomaterials (Basel); 2021 Jan; 11(1):. PubMed ID: 33467416
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cancer Cell Membrane Decorated Silica Nanoparticle Loaded with miR495 and Doxorubicin to Overcome Drug Resistance for Effective Lung Cancer Therapy.
    He J; Gong C; Qin J; Li M; Huang S
    Nanoscale Res Lett; 2019 Nov; 14(1):339. PubMed ID: 31705398
    [TBL] [Abstract][Full Text] [Related]  

  • 98. GSH-responsive curcumin/doxorubicin encapsulated Bactrian camel serum albumin nanocomposites with synergistic effect against lung cancer cells.
    Yu X; Xieripu A; Xu Q; Zulipikaer A; Song Y; Cai L; Chen J
    J Biomed Res; 2019 Aug; 34(1):54-66. PubMed ID: 35081683
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling.
    Raposo CD; Costa R; Petrova KT; Brito C; Scotti MT; Cardoso MM
    Polymers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947904
    [TBL] [Abstract][Full Text] [Related]  

  • 100. M1 Macrophage-Biomimetic Targeted Nanoparticles Containing Oxygen Self-Supplied Enzyme for Enhancing the Chemotherapy.
    Zhang J; Gu B; Wu S; Liu L; Gao Y; Yao Y; Yang D; Du J; Yang C
    Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.